Citations

Clear

382 citation(s) found for "Li, Man".

Circadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas
Visentin, R. , Man, Chiara Dalla , Kudva, Yogish C. , Basu, Ananda , Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Diabetes Technology & Therapeutics | December 22, 2014 | Volume: 17 | Issue: 1 | Pages: 1-7

10.1089/dia.2014.0192 | PMID 25531427 Get It

The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor
Parmar, Priya , Krishnamurthi, Rita , Ikram, M. Arfan , Hofman, Albert , Mirza, Saira Saeed , Varakin, Yury, Kravchenko, Michael , Пирадов, М. А. , Thrift, Amanda G. , Wang, Wenzhi , Mandal, Dipes Kumar , Barker‐Collo, Suzanne , Sahathevan, Ramesh , Saposnik, Gustavo , Sindi, Shireen , Bornstein, Natan M. , Giroud, Maurice , Béjot, Yannick , Brainin, Michael , Narayan, K M Venkat, Correia, Manuel , Kokubo, Yoshihiro , Wiebers, David O. , BinDhim, Nasser F. , Barber, P. Alan , Pandian, Jeyaraj , Hankey, Graeme J. , Mehndiratta, Man Mohan , Azhagammal, Shobhana, Ibrahim, Norlinah Mohd, Abbott, Max , Hume, Patria , Hussein, Tasleem, Bhattacharjee, Rohit, Purohit, Mitali, Feigin, Valery L. , Narayan, K.M. Venkat , Mirza, Saira Saeed , Varakin, Yu. Ya., Norrving, Bo , Davis, Stephen M. , Kivipelto, Miia , Poulton, Richie , Freire, Antônio Fernando Menezes , Mensah, George A. , Rush, Elaine Carolyn , Hankey, Graeme J , Pandian, Jeyaraj , Kravchenko, Michael , Thrift, Amanda , Ibrahim, Norlinah Mohamed

Mayo Clinic

International Journal of Stroke | December 10, 2014 | Volume: 10 | Issue: 2 | Pages: 231-244

10.1111/ijs.12411 | PMID 25491651 Get It

Background The greatest potential to reduce the burden of stroke is by primary prevention of first-ever stroke, which constitutes three quarters of all stroke. In addition to population-wide prevention strategies (the ‘mass’ approach), the ‘high risk’ approach aims to identify individuals at risk of stroke and to modify their risk factors, and risk, accordingly. Current methods of assessing and modifying stroke risk are difficult to access and implement by the general population, amongst whom most future strokes will arise. To help reduce the burden of stroke on individuals and the population a new app, the Stroke Riskometer™, has been developed. We aim to explore the validity of the app for predicting the risk of stroke compared with current best methods. Methods 752 stroke outcomes from a sample of 9501 individuals across three countries (New Zealand, Russia and the Netherlands) were utilized to investigate the performance of a novel stroke risk prediction tool algorithm (Stroke Riskometer™) compared with two established stroke risk score prediction algorithms (Framingham Stroke Risk Score [FSRS] and QStroke). We calculated the receiver operating characteristics (ROC) curves and area under the ROC curve (AUROC) with 95% confidence intervals, Harrels C-statistic and D-statistics for measure of discrimination, R2 statistics to indicate level of variability accounted for by each prediction algorithm, the Hosmer-Lemeshow statistic for calibration, and the sensitivity and specificity of each algorithm. Results The Stroke Riskometer™ performed well against the FSRS five-year AUROC for both males (FSRS = 75·0% (95% CI 72·3%–77·6%), Stroke Riskometer™ = 74·0(95% CI 71·3%–76·7%) and females [FSRS = 70·3% (95% CI 67·9%–72·8%, Stroke Riskometer™ = 71·5% (95% CI 69·0%–73·9%)], and better than QStroke [males–59·7% (95% CI 57·3%–62·0%) and comparable to females = 71·1% (95% CI 69·0%–73·1%)]. Discriminative ability of all algorithms was low (C-statistic ranging from 0·51–0·56, D-statistic ranging from 0·01–0·12). Hosmer-Lemeshow illustrated that all of the predicted risk scores were not well calibrated with the observed event data ( P < 0·006). Conclusions The Stroke Riskometer™ is comparable in performance for stroke prediction with FSRS and QStroke. All three algorithms performed equally poorly in predicting stroke events. The Stroke Riskometer™ will be continually developed and validated to address the need to improve the current stroke risk scoring systems to more accurately predict stroke, particularly by identifying robust ethnic/race ethnicity group and country specific risk factors.
Tourette syndrome deep brain stimulation: A review and updated recommendations
Schrock, Lauren E. , Woods, Douglas W. , Porta, Mauro, Servello, Domenico , Silburn, Peter A., Walker, Harrison C. , Shahed‐Jimenez, Joohi, Savica, Rodolfo , Klassen, Bryan T. , Foote, Kelly D. , Ackermans, Linda , Temel, Yasin , Changizi, Barbara Kelly , Lozano, Andrés M. , Auyeung, M., Kaido, Takanobu, Agid, Yves, Welter, Marie Laure, Khandhar, Suketu M., Pourfar, Michael , Walter, Benjamin L. , Juncos, Jorge L., Leckman, James F. , Neimat, Joseph A, Okun, Michael S. , Jimenez‐Shahed, Joohi , Mink, Jonathan W. , Visser-Vandewalle, Veerle E. R. M. , Foltynie, Thomas , Machado, André G. , Zhang, Jianguo , Hu, Wei , Mari, Zoltan K. , Auyeung, Man , Mogilner, Alon Y. , Gross, Robert E. , Kuhn, Jens , Okun, Michael S , Leckman, James F , Walter, Benjamin L , Jimenez-Shahed, Joohi , Welter, Marie‐Laure

Mayo Clinic

Movement Disorders | December 8, 2014 | Volume: 30 | Issue: 4 | Pages: 448-471

10.1002/mds.26094 | PMID 25476818 Get It

Abstract Deep brain stimulation (DBS) may improve disabling tics in severely affected medication and behaviorally resistant Tourette syndrome (TS). Here we review all reported cases of TS DBS and provide updated recommendations for selection, assessment, and management of potential TS DBS cases based on the literature and implantation experience. Candidates should have a Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition (DSM V) diagnosis of TS with severe motor and vocal tics, which despite exhaustive medical and behavioral treatment trials result in significant impairment. Deep brain stimulation should be offered to patients only by experienced DBS centers after evaluation by a multidisciplinary team. Rigorous preoperative and postoperative outcome measures of tics and associated comorbidities should be used. Tics and comorbid neuropsychiatric conditions should be optimally treated per current expert standards, and tics should be the major cause of disability. Psychogenic tics, embellishment, and malingering should be recognized and addressed. We have removed the previously suggested 25‐year‐old age limit, with the specification that a multidisciplinary team approach for screening is employed. A local ethics committee or institutional review board should be consulted for consideration of cases involving persons younger than 18 years of age, as well as in cases with urgent indications. Tourette syndrome patients represent a unique and complex population, and studies reveal a higher risk for post‐DBS complications. Successes and failures have been reported for multiple brain targets; however, the optimal surgical approach remains unknown. Tourette syndrome DBS, though still evolving, is a promising approach for a subset of medication refractory and severely affected patients. © 2014 International Parkinson and Movement Disorder Society
Poster 211 Crohn's, Groans, and Bones: Thoracic Pain in a 70‐year‐old Man ‐ A Case Report
Lueders, Daniel , Hatch, Bryndon B., Weber, David C.

Mayo Clinic

PM&R | September 29, 2014 | Volume: 6 | Issue: 9S | Pages: No page available

10.1016/j.pmrj.2014.08.603 Get It

An Unusual Case of Osteoblastic Metastasis from Gastric Carcinoma
Ha, Chang Young, Kim, Hyeon Man, Lee, Kwang Jae , Park, Chan H., Fitzpatr, Lorraine A., Chung, Yoon‐Sok , Choi, Tae‐Young

Mayo Clinic

Yonsei Medical Journal | September 27, 2014 | Volume: 43 | Issue: 3 | Pages: 377

10.3349/ymj.2002.43.3.377 | PMID 12089748 Get It

Tenosynovitis Caused by a Novel Nontuberculous Mycobacterium Species Initially Misidentified as a Member of the Mycobacterium tuberculosis Complex
Simner, Patricia J. , Hyle, Emily P. , Buckwalter, Seanne P., Branda, John A. , Brown‐Elliott, Barbara A. , Franklin, Jameelah Atiya, Toney, Nadege C. , Man, Tom J. B. de , Wallace, Richard J. , Vasireddy, Ravikiran, Gandhi, Rajesh T. , Wengenack, Nancy L.

Mayo Clinic

Journal of Clinical Microbiology | September 25, 2014 | Volume: 52 | Issue: 12 | Pages: 4414-4418

10.1128/jcm.00967-14 | PMID 25253791 Get It

ABSTRACT We present a case of tenosynovitis caused by a novel, slowly growing, nonchromogenic, nontuberculous mycobacterium (NTM). Originally misidentified as Mycobacterium tuberculosis complex, the NTM cross-reacts with the M. tuberculosis complex nucleic acid hybridization probe, a M. tuberculosis gamma interferon release assay, and is closely related to M. tuberculosis by 16S rRNA gene sequencing.
Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function
Hinshaw, Ling , Schiavon, Michele , Mallad, Ashwini , Man, Chiara Dalla , Basu, Rita , Bharucha, Adil E. , Carter, Rickey E. , Basu, Ananda , Kudva, Yogish C. , Cobelli, Claudio , Dalla Man, Chiara , Carter, Rickey E , Schiavon, Michele

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | July 30, 2014 | Volume: 307 | Issue: 6 | Pages: E494-E502

10.1152/ajpendo.00199.2014 | PMID 25074985 Get It

Controlling meal-related glucose excursions continues to be a therapeutic challenge in diabetes mellitus. Mechanistic reasons for this need to be understood better to develop appropriate therapies. To investigate delayed gastric emptying effects on postprandial glucose turnover, insulin sensitivity, and β-cell responsivity and function, as a feasibility study prior to studying patients with type 1 diabetes, we used the triple tracer technique C-peptide and oral minimal model approach in healthy subjects. A single dose of 30 μg of pramlintide administered at the start of a mixed meal was used to delay gastric emptying rates. With delayed gastric emptying rates, peak rate of meal glucose appearance was delayed, and rate of endogenous glucose production (EGP) was lower. C-peptide and oral minimal models enabled the assessments of β-cell function, insulin sensitivity, and β-cell responsivity simultaneously. Delayed gastric emptying induced by pramlintide improved total insulin sensitivity and decreased total β-cell responsivity. However, β-cell function as measured by total disposition index did not change. The improved whole body insulin sensitivity coupled with lower rate of appearance of EGP with delayed gastric emptying provides experimental proof of the importance of evaluating pramlintide in artificial endocrine pancreas approaches to reduce postprandial blood glucose variability in patients with type 1 diabetes.
Clinical Reasoning: A 69-year-old man with leukocytosis and hemorrhagic brain lesions
Scott, Kristin M., Gardner, F., Eidelman, Benjamin H., Rivera, Candido E., Menke, David M. , Barrett, Kevin M. , Gardner, Faithlore P

Mayo Clinic

Neurology | June 30, 2014 | Volume: 83 | Issue: 1 | Pages: No page available

10.1212/wnl.0000000000000542 | PMID 24982042 Get It

Clinical Reasoning: A 55-year-old man with weight loss, ataxia, and foot drop
Flanagan, Eoin P. , Kumar, Neeraj , Krecke, Karl N. , Katz, Brian, Pittock, Sean J. , Leep Hunderfund, Andrea N, Katz, Brian S, Hunderfund, Andrea N. Leep , Murray, Joseph A. , Pittock, S J , Flanagan, E P

Mayo Clinic

Neurology | June 17, 2014 | Volume: 82 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000000525 | PMID 24960835 Get It